Drug-Induced Liver Disturbance During the Treatment of COVID-19

An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China, at the end of 2019. The World Health Organization named the resulting infectious disease as coronavirus disease-2019 (COVID-19). Many studies concluded that patients infected with SARS-CoV-2 have di...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Guanghua, Li, Meifen, Wang, Ying, Wu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416279/
https://www.ncbi.nlm.nih.gov/pubmed/34483929
http://dx.doi.org/10.3389/fphar.2021.719308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416279/
https://www.ncbi.nlm.nih.gov/pubmed/34483929
http://dx.doi.org/10.3389/fphar.2021.719308

Ejemplares similares